Latest Strategy Changes News

Santos delivered a steady first quarter with production up 3% year-on-year, driven by Barossa's initial cargoes and Pikka phase 1 nearing first oil. Free cash flow held firm at $383 million, while a key Moomba optimisation project received final investment approval.

DigitalX Limited closed the March 2026 quarter with A$59.5 million in liquid assets, unveiling a A$30 million strategic investment program and delivering record revenue from its Sell My Shares platform, signalling a pivot towards disciplined capital deployment and sustainable growth.

Doctor Care Anywhere posted an 8.4% quarterly jump in consultations and sustained positive cashflow for the fourth consecutive quarter, while launching new digital health initiatives and reaffirming its medium-term revenue and profitability targets.

Burley Minerals has reignited interest in its Chubb Lithium Project in Quebec following a lithium price uptick and promising drilling results revealing both spodumene and rare pollucite mineralisation. The company is weighing strategic options including further exploration, joint ventures, or sale.

Beam Communications (ASX:BCC) reported a modest operating cash inflow of $64K in Q3 FY26, driven by aggressive cost cuts after exiting the Zoleo business. The company’s cash pile surged to $16.4 million following the Zoleo divestment, underpinning a proposed $0.14 per share capital return.

Cavalier Resources has secured a $4 million placement at an 11.95% discount to the 15-day VWAP, funding critical pre-production activities at its Crawford Gold Project. This capital injection complements ongoing negotiations for a US$13 million gold prepayment and a A$5 million loan, advancing the project toward production.

First Graphene has demonstrated a significant carbon reduction in cement roof tiles through a UK production trial with FP McCann, using graphene-enhanced cement to lower emissions and material use.

Adelong Gold’s latest drilling at Lauriston validates historic gold grades at Comet and reveals an emerging antimony system at Trojan, signalling potential for a significant gold-antimony corridor in Victoria.

Radiopharm Theranostics (ASX: RAD) has completed enrolment in its Phase 2b RAD 101 brain metastases imaging trial with interim data showing 90% concordance with MRI, while progressing early-stage trials of therapeutic candidates RAD 202, RV-01, and RAD 402. The company reported a $19.2 million cash balance at quarter end, down from $34.5 million, with a net operating cash outflow of $14.9 million driven by milestone-related R&D and staff costs.

Wellnex Life has pushed back the repayment deadline on nearly $3 million owed to former directors by three months, agreeing to additional fees and interest. Former CEO Zack Bozinovski returns as a consultant, suggesting ongoing strategic recalibration.

Aldoro Resources has achieved an exceptional ~99% strontium extraction from its Kameelburg Project ore using simple ambient-temperature acid leaching, positioning the asset as a rare, low-complexity source amid soaring global strontium prices and supply disruptions.

Barton Gold has launched a ~3,000m diamond drilling campaign at its Tunkillia project, aiming to upgrade resources and support a Mining Lease application by the end of 2026. The project builds on a strong May 2025 study projecting robust returns amid rising gold and silver prices.